Barclays PLC Opko Health, Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Opko Health, Inc. stock. As of the latest transaction made, Barclays PLC holds 664,407 shares of OPK stock, worth $903,593. This represents 0.0% of its overall portfolio holdings.

Number of Shares

664,407

Previous 664,407 -0.0%

Holding current value

$903,593

Previous $877,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.24 - $1.66 $337,795 - $452,210	272,416 Added 69.5%	664,407 $877,000
Q1 2025 May 15, 2025	SELL	$1.45 - $1.94 $760,346 - $1.02 Million	-524,377 Reduced 57.22%	391,991 $650,000
Q4 2024 Feb 13, 2025	BUY	$1.4 - $1.64 $522,244 - $611,772	373,032 Added 68.66%	916,368 $1.35 Million
Q3 2024 Nov 15, 2024	BUY	$1.21 - $1.68 $399,142 - $554,181	329,870 Added 154.53%	543,336 $810,000
Q2 2024 Aug 14, 2024	SELL	$1.21 - $1.42 $279,081 - $327,517	-230,646 Reduced 51.93%	213,466 $267,000
Q1 2024 May 15, 2024	SELL	$0.87 - $1.57 $281,850 - $508,626	-323,966 Reduced 42.18%	444,112 $533,000
Q4 2023 Feb 15, 2024	BUY	$1.23 - $1.63 $712,978 - $944,840	579,657 Added 307.64%	768,078 $1.16 Million
Q3 2023 Nov 07, 2023	BUY	$1.5 - $2.17 $41,919 - $60,642	27,946 Added 17.41%	188,421 $302,000
Q2 2023 Aug 03, 2023	SELL	$1.37 - $2.17 $61,095 - $96,771	-44,595 Reduced 21.75%	160,475 $348,000
Q1 2023 May 04, 2023	BUY	$1.06 - $1.61 $102,463 - $155,629	96,664 Added 89.17%	205,070 $300,000
Q4 2022 Feb 13, 2023	BUY	$1.05 - $2.01 $95,852 - $183,488	91,288 Added 533.29%	108,406 $135,000
Q3 2022 Nov 03, 2022	SELL	$1.81 - $2.81 $73,306 - $113,807	-40,501 Reduced 70.29%	17,118 $32,000
Q2 2022 Aug 12, 2022	SELL	$2.33 - $3.61 $21,648 - $33,540	-9,291 Reduced 13.89%	57,619 $146,000
Q1 2022 May 16, 2022	SELL	$2.87 - $4.93 $1.26 Million - $2.16 Million	-438,103 Reduced 86.75%	66,910 $230,000
Q4 2021 Feb 14, 2022	BUY	$3.52 - $5.15 $1.01 Million - $1.47 Million	286,073 Added 130.66%	505,013 $2.43 Million
Q3 2021 Nov 09, 2021	BUY	$3.44 - $4.24 $374,086 - $461,083	108,746 Added 98.69%	218,940 $799,000
Q2 2021 Aug 13, 2021	SELL	$3.33 - $4.55 $951,044 - $1.3 Million	-285,599 Reduced 72.16%	110,194 $446,000
Q1 2021 May 13, 2021	BUY	$4.19 - $5.99 $976,320 - $1.4 Million	233,012 Added 143.14%	395,793 $1.7 Million
Q4 2020 Feb 11, 2021	SELL	$3.27 - $4.87 $70,249 - $104,622	-21,483 Reduced 11.66%	162,781 $643,000
Q3 2020 Nov 12, 2020	SELL	$2.99 - $5.96 $202,757 - $404,159	-67,812 Reduced 26.9%	184,264 $680,000
Q2 2020 Aug 12, 2020	BUY	$1.15 - $3.41 $142,555 - $422,707	123,961 Added 96.76%	252,076 $860,000
Q1 2020 May 13, 2020	SELL	$1.34 - $2.32 $454,854 - $787,510	-339,444 Reduced 72.6%	128,115 $172,000
Q4 2019 Feb 10, 2020	BUY	$1.42 - $2.17 $239,846 - $366,526	168,906 Added 56.56%	467,559 $688,000
Q3 2019 Nov 14, 2019	SELL	$1.75 - $2.47 $1.02 Million - $1.43 Million	-580,758 Reduced 66.04%	298,653 $623,000
Q2 2019 Aug 14, 2019	BUY	$1.79 - $2.61 $1.4 Million - $2.04 Million	780,453 Added 788.67%	879,411 $2.15 Million
Q1 2019 May 15, 2019	SELL	$2.42 - $3.83 $137,654 - $217,858	-56,882 Reduced 36.5%	98,958 $258,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $3.87 $267,652 - $421,063	-108,802 Reduced 41.11%	155,840 $468,000
Q3 2018 Nov 14, 2018	BUY	$3.29 - $6.29 $138,239 - $264,293	42,018 Added 18.87%	264,642 $916,000
Q2 2018 Aug 14, 2018	BUY	$2.99 - $4.99 $182,252 - $304,160	60,954 Added 37.7%	222,624 $1.05 Million
Q1 2018 May 15, 2018	SELL	$3.11 - $5.12 $10,987 - $18,088	-3,533 Reduced 2.14%	161,670 $512,000
Q4 2017 Feb 14, 2018	SELL	$4.61 - $7.04 $778,347 - $1.19 Million	-168,839 Reduced 50.54%	165,203 $809,000
Q3 2017 Nov 14, 2017	BUY	$5.88 - $7.11 $1.96 Million - $2.38 Million	334,042	334,042 $2.29 Million

Others Institutions Holding OPK

# of Institutions

246

Shares Held

207M

Call Options Held

1.49M

Put Options Held

332K

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.05B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account